Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine

NCT01506570 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

NIH

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: TetraVax-DV Vaccine - Admixture TV003
BIOLOGICAL: TetraVax-DV Vaccine - Admixture TV005
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)